SuperworthEli Lilly and shares outstanding LLY
Diluted shares outstanding, averaged over each quarter, from 1995.
- Latest quarter, to Jun 30, 2026
- 893.7M
- On a year earlier
- −0.7%
- fewer shares
Eli Lilly and had 893.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 0.7% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 898M | −1% |
| FY2024 | 903.2M | −0% |
| FY2023 | 904M | −0% |
| FY2022 | 904.7M | −1% |
| FY2021 | 909.6M | −0% |
| FY2020 | 912.6M | −0% |
| FY2019 | 915.8M | −10% |
| FY2018 | 1B | −2% |
| FY2017 | 1B | −2% |
| FY2016 | 1.1B | −0% |
| FY2015 | 1.1B | −0% |
| FY2014 | 1.1B | −1% |
| FY2013 | 1.1B | −3% |
| FY2012 | 1.1B | −0% |
| FY2011 | 1.1B | +1% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 893.7M | −1% | |
| Q1 FY26 | 895.9M | −1% | |
| Q4 FY25 | 898M | −1% | |
| Q3 FY25 | 898.8M | −1% | |
| Q2 FY25 | 899.8M | −0% | |
| Q1 FY25 | 900.6M | −0% | |
| Q4 FY24 | 903.2M | −0% | |
| Q3 FY24 | 905M | +1% | |
| Q2 FY24 | 904.2M | +0% | |
| Q1 FY24 | 903.8M | +0% | |
| Q4 FY23 | 904M | −0% | |
| Q3 FY23 | 899.8M | −0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Eli Lilly and
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.